In this episode of Mommy Brain Revisited I talk with Dr. Kristina M. Deligiannidis, MD, Professor, Institute of Behavioral Science, Feinstein Institutes for Medical Research, Director, Women’s Behavioral Health, Zucker Hillside Hospital, Northwell Health, Professor, Psychiatry, Molecular Medicine and Obstetrics & Gynecology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, USA.

We talk about her research on the development of neurosteroid treatments for postpartum depression.

In particular we talk about her work on the new FDA approved oral medication for postpartum depression – Zuranolone as well as some practical information on Zuranolone, itself.

Don’t miss this episode on Mommy Brain Revisited. It’s an important one for understanding the current treatment options and challenges for perinatal mental illness.

For more information on Dr Deligiannidis’ work and her contact information see:

https://feinstein.northwell.edu/institutes-researchers/our-researchers/kristina-m-deligiannidis-md

Download one of the publications that we talk about here: https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.20220785